Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-01

AUTHORS

K. N. Chi, A. Tolcher, P. Lee, P. J. Rosen, C. K. Kollmannsberger, K. P. Papadopoulos, A. Patnaik, A. Molina, J. Jiao, C. Pankras, B. Kaiser, A. Bernard, N. Tran, M. Acharya

ABSTRACT

PURPOSE: To assess the effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan HBr (CYP2D6 substrate) and theophylline (CYP1A2 substrate) in patients with metastatic castration-resistant prostate cancer (mCRPC). METHODS: Men with progressive metastatic mCRPC who failed gonadotropin-releasing hormone therapy and ≥1 lines of chemotherapy were enrolled. Patients received two doses of dextromethorphan HBr-30 mg (n = 18; group A) or theophylline-100 mg (n = 16; group B) under fasting conditions; one dose on cycle 1, day -8, and the other dose on cycle 1, day 8. Only patients with extensive CYP2D6 metabolizing status were assigned to group A. All patients received continuous daily oral abiraterone acetate (1,000 mg) plus prednisone (10 mg) starting on cycle 1, day 1. RESULTS: Coadministration of abiraterone acetate plus prednisone increased the systemic exposure of dextromethorphan by approximately 100%. Ratios of geometric means for maximum plasma concentration (C(max)) (275.36%) and area under plasma concentration-time curves from time 0 to 24 h (AUC(24h)) (268.14%) of dextromethorphan were outside the bioequivalence limit. The pharmacokinetics of theophylline was unaltered following coadministration of abiraterone acetate plus prednisone. Ratios of geometric means [C(max); 102.36% and AUC(24h); 108.03%] of theophylline exposure parameters were within the bioequivalence limit. The safety profile of abiraterone acetate was consistent with reported toxicities. CONCLUSION: Abiraterone acetate plus prednisone increased the exposure of dextromethorphan, suggesting a need for caution when coadministrating with known CYP2D6 substrates. The pharmacokinetics of theophylline was unaffected when coadministered with abiraterone acetate plus prednisone. More... »

PAGES

237-244

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00280-012-2001-0

DOI

http://dx.doi.org/10.1007/s00280-012-2001-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1022092108

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23064959


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Abiraterone Acetate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Androstadienes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Area Under Curve", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytochrome P-450 CYP1A2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytochrome P-450 CYP2D6", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dextromethorphan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Interactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Metastasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prednisone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Theophylline", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "BC Cancer Agency", 
          "id": "https://www.grid.ac/institutes/grid.248762.d", 
          "name": [
            "British Columbia Cancer Agency, 600 West 10th Avenue, V5Z4E6, Vancouver, BC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chi", 
        "givenName": "K. N.", 
        "id": "sg:person.01142252161.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142252161.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "South Texas Accelerated Research Therapeutics", 
          "id": "https://www.grid.ac/institutes/grid.477989.c", 
          "name": [
            "South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tolcher", 
        "givenName": "A.", 
        "id": "sg:person.013317163017.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013317163017.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tower Cancer Research Foundation", 
          "id": "https://www.grid.ac/institutes/grid.478023.a", 
          "name": [
            "Tower Cancer Research Foundation, Beverly Hills, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "P.", 
        "id": "sg:person.01022031333.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022031333.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Providence Saint Joseph Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.490448.5", 
          "name": [
            "Providence Saint Joseph Medical Center, Burbank, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rosen", 
        "givenName": "P. J.", 
        "id": "sg:person.0724042407.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724042407.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "BC Cancer Agency", 
          "id": "https://www.grid.ac/institutes/grid.248762.d", 
          "name": [
            "British Columbia Cancer Agency, 600 West 10th Avenue, V5Z4E6, Vancouver, BC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kollmannsberger", 
        "givenName": "C. K.", 
        "id": "sg:person.0660645031.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660645031.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "South Texas Accelerated Research Therapeutics", 
          "id": "https://www.grid.ac/institutes/grid.477989.c", 
          "name": [
            "South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Papadopoulos", 
        "givenName": "K. P.", 
        "id": "sg:person.011133434022.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011133434022.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "South Texas Accelerated Research Therapeutics", 
          "id": "https://www.grid.ac/institutes/grid.477989.c", 
          "name": [
            "South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Patnaik", 
        "givenName": "A.", 
        "id": "sg:person.01036311176.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036311176.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "RAND Corporation", 
          "id": "https://www.grid.ac/institutes/grid.34474.30", 
          "name": [
            "Janssen Research and Development LLC, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Molina", 
        "givenName": "A.", 
        "id": "sg:person.012576447577.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012576447577.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Janssen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.497530.c", 
          "name": [
            "Janssen Research and Development LLC, Raritan, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jiao", 
        "givenName": "J.", 
        "id": "sg:person.01023060661.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023060661.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "BC Cancer Agency", 
          "id": "https://www.grid.ac/institutes/grid.248762.d", 
          "name": [
            "British Columbia Cancer Agency, 600 West 10th Avenue, V5Z4E6, Vancouver, BC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pankras", 
        "givenName": "C.", 
        "id": "sg:person.01205422461.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205422461.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "South Texas Accelerated Research Therapeutics", 
          "id": "https://www.grid.ac/institutes/grid.477989.c", 
          "name": [
            "South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaiser", 
        "givenName": "B.", 
        "id": "sg:person.01173433761.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173433761.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Janssen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.497530.c", 
          "name": [
            "Janssen Research and Development LLC, Raritan, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bernard", 
        "givenName": "A.", 
        "id": "sg:person.0721703640.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721703640.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "RAND Corporation", 
          "id": "https://www.grid.ac/institutes/grid.34474.30", 
          "name": [
            "Janssen Research and Development LLC, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tran", 
        "givenName": "N.", 
        "id": "sg:person.01253535661.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253535661.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Janssen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.497530.c", 
          "name": [
            "Janssen Research and Development LLC, Raritan, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Acharya", 
        "givenName": "M.", 
        "id": "sg:person.01253457116.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253457116.57"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s0140-6736(10)61389-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005976220"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.20.0642", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011914597"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2710.2007.00815.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012333988"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.24.1281", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013861469"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-08-0249", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017269047"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1014618", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018044872"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.25.9259", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026303880"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2125.1998.00719.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027361200"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2125.1998.00719.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027361200"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa041318", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028543233"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa040720", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029249997"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.12.4487", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031178629"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002512-200320100-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031740200", 
          "https://doi.org/10.2165/00002512-200320100-00005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002512-200320100-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031740200", 
          "https://doi.org/10.2165/00002512-200320100-00005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.24.6819", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033684430"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdq050", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037456851"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6601879", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037763577", 
          "https://doi.org/10.1038/sj.bjc.6601879"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6601879", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037763577", 
          "https://doi.org/10.1038/sj.bjc.6601879"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-11-0815", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038628088"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-07-5997", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051493123"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdl498", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051931730"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3322/ca.2007.0010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052065817"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm950749y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055957296"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm950749y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055957296"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00008571-199204000-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060289224"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00008571-199204000-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060289224"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00008571-199204000-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060289224"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/0929867054367185", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069160512"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079893102", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-01", 
    "datePublishedReg": "2013-01-01", 
    "description": "PURPOSE: To assess the effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan HBr (CYP2D6 substrate) and theophylline (CYP1A2 substrate) in patients with metastatic castration-resistant prostate cancer (mCRPC).\nMETHODS: Men with progressive metastatic mCRPC who failed gonadotropin-releasing hormone therapy and \u22651 lines of chemotherapy were enrolled. Patients received two doses of dextromethorphan HBr-30 mg (n = 18; group A) or theophylline-100 mg (n = 16; group B) under fasting conditions; one dose on cycle 1, day -8, and the other dose on cycle 1, day 8. Only patients with extensive CYP2D6 metabolizing status were assigned to group A. All patients received continuous daily oral abiraterone acetate (1,000 mg) plus prednisone (10 mg) starting on cycle 1, day 1.\nRESULTS: Coadministration of abiraterone acetate plus prednisone increased the systemic exposure of dextromethorphan by approximately 100%. Ratios of geometric means for maximum plasma concentration (C(max)) (275.36%) and area under plasma concentration-time curves from time 0 to 24 h (AUC(24h)) (268.14%) of dextromethorphan were outside the bioequivalence limit. The pharmacokinetics of theophylline was unaltered following coadministration of abiraterone acetate plus prednisone. Ratios of geometric means [C(max); 102.36% and AUC(24h); 108.03%] of theophylline exposure parameters were within the bioequivalence limit. The safety profile of abiraterone acetate was consistent with reported toxicities.\nCONCLUSION: Abiraterone acetate plus prednisone increased the exposure of dextromethorphan, suggesting a need for caution when coadministrating with known CYP2D6 substrates. The pharmacokinetics of theophylline was unaffected when coadministered with abiraterone acetate plus prednisone.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00280-012-2001-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "71"
      }
    ], 
    "name": "Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer", 
    "pagination": "237-244", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "694070b75dea6cefc8c358b315f9057b6ff3ea4dcd1c56132bbe60d20243e703"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23064959"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7806519"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00280-012-2001-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1022092108"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00280-012-2001-0", 
      "https://app.dimensions.ai/details/publication/pub.1022092108"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T18:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8675_00000512.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00280-012-2001-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00280-012-2001-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00280-012-2001-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00280-012-2001-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00280-012-2001-0'


 

This table displays all metadata directly associated to this object as RDF triples.

305 TRIPLES      21 PREDICATES      67 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00280-012-2001-0 schema:about N1375327fa5264f4ebc466345ff548345
2 N1c652fe57fe240408de44776986e6d52
3 N247505d6f2224bb3b6ec4b2d94380068
4 N2cd0b71125fa4c9d9307f6a184c4eff9
5 N2f53e2196f154ebabb27224e58a1b37b
6 N42e1f4ee68904e7b8079b9cd7ba3aac9
7 N4dc6ab8f9a994734906978a513a48876
8 N56124cec5b8c46edb7391522e38018b1
9 N666407c487804614b171c1c9c8d53f6e
10 N7199fa0460a54b16bf4e366c1ae83a76
11 N99be9e7fc6fb4f63900bae25df1b17c6
12 Na5e6fa92bc7546d5b03d80839e309095
13 Nd37c4e1a25c24c67aea592cf6d9a0a52
14 Nddbac803a0894df6b37dae821b5adfbc
15 Nf98543535aae4cabaa15a3f295d7e62e
16 anzsrc-for:11
17 anzsrc-for:1117
18 schema:author Naf9c1a8e89694f0484699bb757c7da53
19 schema:citation sg:pub.10.1038/sj.bjc.6601879
20 sg:pub.10.2165/00002512-200320100-00005
21 https://app.dimensions.ai/details/publication/pub.1079893102
22 https://doi.org/10.1016/s0140-6736(10)61389-x
23 https://doi.org/10.1021/jm950749y
24 https://doi.org/10.1046/j.1365-2125.1998.00719.x
25 https://doi.org/10.1056/nejmoa040720
26 https://doi.org/10.1056/nejmoa041318
27 https://doi.org/10.1056/nejmoa1014618
28 https://doi.org/10.1093/annonc/mdl498
29 https://doi.org/10.1093/annonc/mdq050
30 https://doi.org/10.1097/00008571-199204000-00004
31 https://doi.org/10.1111/j.1365-2710.2007.00815.x
32 https://doi.org/10.1158/0008-5472.can-07-5997
33 https://doi.org/10.1158/0008-5472.can-08-0249
34 https://doi.org/10.1158/1078-0432.ccr-11-0815
35 https://doi.org/10.1200/jco.2007.12.4487
36 https://doi.org/10.1200/jco.2008.20.0642
37 https://doi.org/10.1200/jco.2009.24.1281
38 https://doi.org/10.1200/jco.2009.24.6819
39 https://doi.org/10.1200/jco.2009.25.9259
40 https://doi.org/10.2174/0929867054367185
41 https://doi.org/10.3322/ca.2007.0010
42 schema:datePublished 2013-01
43 schema:datePublishedReg 2013-01-01
44 schema:description PURPOSE: To assess the effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan HBr (CYP2D6 substrate) and theophylline (CYP1A2 substrate) in patients with metastatic castration-resistant prostate cancer (mCRPC). METHODS: Men with progressive metastatic mCRPC who failed gonadotropin-releasing hormone therapy and ≥1 lines of chemotherapy were enrolled. Patients received two doses of dextromethorphan HBr-30 mg (n = 18; group A) or theophylline-100 mg (n = 16; group B) under fasting conditions; one dose on cycle 1, day -8, and the other dose on cycle 1, day 8. Only patients with extensive CYP2D6 metabolizing status were assigned to group A. All patients received continuous daily oral abiraterone acetate (1,000 mg) plus prednisone (10 mg) starting on cycle 1, day 1. RESULTS: Coadministration of abiraterone acetate plus prednisone increased the systemic exposure of dextromethorphan by approximately 100%. Ratios of geometric means for maximum plasma concentration (C(max)) (275.36%) and area under plasma concentration-time curves from time 0 to 24 h (AUC(24h)) (268.14%) of dextromethorphan were outside the bioequivalence limit. The pharmacokinetics of theophylline was unaltered following coadministration of abiraterone acetate plus prednisone. Ratios of geometric means [C(max); 102.36% and AUC(24h); 108.03%] of theophylline exposure parameters were within the bioequivalence limit. The safety profile of abiraterone acetate was consistent with reported toxicities. CONCLUSION: Abiraterone acetate plus prednisone increased the exposure of dextromethorphan, suggesting a need for caution when coadministrating with known CYP2D6 substrates. The pharmacokinetics of theophylline was unaffected when coadministered with abiraterone acetate plus prednisone.
45 schema:genre research_article
46 schema:inLanguage en
47 schema:isAccessibleForFree false
48 schema:isPartOf Nd2e274854e39425fbeb5c2d3246cc235
49 Nfc3acf6fbfa8482eb3bca12b0b15b990
50 sg:journal.1088364
51 schema:name Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer
52 schema:pagination 237-244
53 schema:productId N04c1f89f2073483989e6997515616fd8
54 N1f3c4b94d1e44e69891a283de7c94944
55 Na7261abf03ba4dafa8f5c4cf813e1ec5
56 Nc880e66924a44e9b98e82cc735e11463
57 Ne579d29f765b4dde87f3e5648a554a54
58 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022092108
59 https://doi.org/10.1007/s00280-012-2001-0
60 schema:sdDatePublished 2019-04-10T18:20
61 schema:sdLicense https://scigraph.springernature.com/explorer/license/
62 schema:sdPublisher N7c529cea37a24374968bc453cd9b3451
63 schema:url http://link.springer.com/10.1007%2Fs00280-012-2001-0
64 sgo:license sg:explorer/license/
65 sgo:sdDataset articles
66 rdf:type schema:ScholarlyArticle
67 N04c1f89f2073483989e6997515616fd8 schema:name readcube_id
68 schema:value 694070b75dea6cefc8c358b315f9057b6ff3ea4dcd1c56132bbe60d20243e703
69 rdf:type schema:PropertyValue
70 N08be1f2d330c4173a5c8c16a7e5a93fe rdf:first sg:person.01036311176.08
71 rdf:rest Nc0a5151e935942549e07586f57c675ce
72 N08dc4d133c5d4da189e7f086f5bd3495 rdf:first sg:person.01173433761.69
73 rdf:rest Ne56886a587584ce2b1d87b58f7add7e4
74 N0acaab6fc41a4411a967de936cb9ac1d rdf:first sg:person.0660645031.33
75 rdf:rest N3998ba08d94743ec84ef4cdcb6d171c9
76 N0c58432680c04083a51a909bc2a85c8b rdf:first sg:person.013317163017.31
77 rdf:rest Nde3a05e2b90c45b3bf0c2ca5e9d1fd58
78 N1375327fa5264f4ebc466345ff548345 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Abiraterone Acetate
80 rdf:type schema:DefinedTerm
81 N1c652fe57fe240408de44776986e6d52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Dextromethorphan
83 rdf:type schema:DefinedTerm
84 N1f3c4b94d1e44e69891a283de7c94944 schema:name doi
85 schema:value 10.1007/s00280-012-2001-0
86 rdf:type schema:PropertyValue
87 N22bf071d53cc4ccdb641602007522a91 rdf:first sg:person.01023060661.71
88 rdf:rest N3178ad3b86564f12ae518ae968e72e3b
89 N247505d6f2224bb3b6ec4b2d94380068 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Drug Interactions
91 rdf:type schema:DefinedTerm
92 N2cd0b71125fa4c9d9307f6a184c4eff9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Neoplasm Metastasis
94 rdf:type schema:DefinedTerm
95 N2f53e2196f154ebabb27224e58a1b37b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Androstadienes
97 rdf:type schema:DefinedTerm
98 N3178ad3b86564f12ae518ae968e72e3b rdf:first sg:person.01205422461.29
99 rdf:rest N08dc4d133c5d4da189e7f086f5bd3495
100 N3998ba08d94743ec84ef4cdcb6d171c9 rdf:first sg:person.011133434022.47
101 rdf:rest N08be1f2d330c4173a5c8c16a7e5a93fe
102 N42e1f4ee68904e7b8079b9cd7ba3aac9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Humans
104 rdf:type schema:DefinedTerm
105 N4dc6ab8f9a994734906978a513a48876 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Theophylline
107 rdf:type schema:DefinedTerm
108 N56124cec5b8c46edb7391522e38018b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Prednisone
110 rdf:type schema:DefinedTerm
111 N58c78356a389445fad767532214a41bf rdf:first sg:person.0724042407.50
112 rdf:rest N0acaab6fc41a4411a967de936cb9ac1d
113 N666407c487804614b171c1c9c8d53f6e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Area Under Curve
115 rdf:type schema:DefinedTerm
116 N6c62df35813b4ec5bfd3dbd2306fcfc4 rdf:first sg:person.01253535661.37
117 rdf:rest Ncfe845d91a90460a9049e0c7273126e9
118 N7199fa0460a54b16bf4e366c1ae83a76 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Male
120 rdf:type schema:DefinedTerm
121 N7c529cea37a24374968bc453cd9b3451 schema:name Springer Nature - SN SciGraph project
122 rdf:type schema:Organization
123 N99be9e7fc6fb4f63900bae25df1b17c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Cytochrome P-450 CYP2D6
125 rdf:type schema:DefinedTerm
126 Na5e6fa92bc7546d5b03d80839e309095 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Antineoplastic Combined Chemotherapy Protocols
128 rdf:type schema:DefinedTerm
129 Na7261abf03ba4dafa8f5c4cf813e1ec5 schema:name pubmed_id
130 schema:value 23064959
131 rdf:type schema:PropertyValue
132 Naf9c1a8e89694f0484699bb757c7da53 rdf:first sg:person.01142252161.65
133 rdf:rest N0c58432680c04083a51a909bc2a85c8b
134 Nc0a5151e935942549e07586f57c675ce rdf:first sg:person.012576447577.98
135 rdf:rest N22bf071d53cc4ccdb641602007522a91
136 Nc880e66924a44e9b98e82cc735e11463 schema:name dimensions_id
137 schema:value pub.1022092108
138 rdf:type schema:PropertyValue
139 Ncfe845d91a90460a9049e0c7273126e9 rdf:first sg:person.01253457116.57
140 rdf:rest rdf:nil
141 Nd2e274854e39425fbeb5c2d3246cc235 schema:volumeNumber 71
142 rdf:type schema:PublicationVolume
143 Nd37c4e1a25c24c67aea592cf6d9a0a52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Cytochrome P-450 CYP1A2
145 rdf:type schema:DefinedTerm
146 Nddbac803a0894df6b37dae821b5adfbc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Follow-Up Studies
148 rdf:type schema:DefinedTerm
149 Nde3a05e2b90c45b3bf0c2ca5e9d1fd58 rdf:first sg:person.01022031333.48
150 rdf:rest N58c78356a389445fad767532214a41bf
151 Ne56886a587584ce2b1d87b58f7add7e4 rdf:first sg:person.0721703640.48
152 rdf:rest N6c62df35813b4ec5bfd3dbd2306fcfc4
153 Ne579d29f765b4dde87f3e5648a554a54 schema:name nlm_unique_id
154 schema:value 7806519
155 rdf:type schema:PropertyValue
156 Nf98543535aae4cabaa15a3f295d7e62e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Prostatic Neoplasms
158 rdf:type schema:DefinedTerm
159 Nfc3acf6fbfa8482eb3bca12b0b15b990 schema:issueNumber 1
160 rdf:type schema:PublicationIssue
161 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
162 schema:name Medical and Health Sciences
163 rdf:type schema:DefinedTerm
164 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
165 schema:name Public Health and Health Services
166 rdf:type schema:DefinedTerm
167 sg:journal.1088364 schema:issn 0344-5704
168 1432-0843
169 schema:name Cancer Chemotherapy and Pharmacology
170 rdf:type schema:Periodical
171 sg:person.01022031333.48 schema:affiliation https://www.grid.ac/institutes/grid.478023.a
172 schema:familyName Lee
173 schema:givenName P.
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022031333.48
175 rdf:type schema:Person
176 sg:person.01023060661.71 schema:affiliation https://www.grid.ac/institutes/grid.497530.c
177 schema:familyName Jiao
178 schema:givenName J.
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023060661.71
180 rdf:type schema:Person
181 sg:person.01036311176.08 schema:affiliation https://www.grid.ac/institutes/grid.477989.c
182 schema:familyName Patnaik
183 schema:givenName A.
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036311176.08
185 rdf:type schema:Person
186 sg:person.011133434022.47 schema:affiliation https://www.grid.ac/institutes/grid.477989.c
187 schema:familyName Papadopoulos
188 schema:givenName K. P.
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011133434022.47
190 rdf:type schema:Person
191 sg:person.01142252161.65 schema:affiliation https://www.grid.ac/institutes/grid.248762.d
192 schema:familyName Chi
193 schema:givenName K. N.
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142252161.65
195 rdf:type schema:Person
196 sg:person.01173433761.69 schema:affiliation https://www.grid.ac/institutes/grid.477989.c
197 schema:familyName Kaiser
198 schema:givenName B.
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173433761.69
200 rdf:type schema:Person
201 sg:person.01205422461.29 schema:affiliation https://www.grid.ac/institutes/grid.248762.d
202 schema:familyName Pankras
203 schema:givenName C.
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205422461.29
205 rdf:type schema:Person
206 sg:person.01253457116.57 schema:affiliation https://www.grid.ac/institutes/grid.497530.c
207 schema:familyName Acharya
208 schema:givenName M.
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253457116.57
210 rdf:type schema:Person
211 sg:person.01253535661.37 schema:affiliation https://www.grid.ac/institutes/grid.34474.30
212 schema:familyName Tran
213 schema:givenName N.
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253535661.37
215 rdf:type schema:Person
216 sg:person.012576447577.98 schema:affiliation https://www.grid.ac/institutes/grid.34474.30
217 schema:familyName Molina
218 schema:givenName A.
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012576447577.98
220 rdf:type schema:Person
221 sg:person.013317163017.31 schema:affiliation https://www.grid.ac/institutes/grid.477989.c
222 schema:familyName Tolcher
223 schema:givenName A.
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013317163017.31
225 rdf:type schema:Person
226 sg:person.0660645031.33 schema:affiliation https://www.grid.ac/institutes/grid.248762.d
227 schema:familyName Kollmannsberger
228 schema:givenName C. K.
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660645031.33
230 rdf:type schema:Person
231 sg:person.0721703640.48 schema:affiliation https://www.grid.ac/institutes/grid.497530.c
232 schema:familyName Bernard
233 schema:givenName A.
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721703640.48
235 rdf:type schema:Person
236 sg:person.0724042407.50 schema:affiliation https://www.grid.ac/institutes/grid.490448.5
237 schema:familyName Rosen
238 schema:givenName P. J.
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724042407.50
240 rdf:type schema:Person
241 sg:pub.10.1038/sj.bjc.6601879 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037763577
242 https://doi.org/10.1038/sj.bjc.6601879
243 rdf:type schema:CreativeWork
244 sg:pub.10.2165/00002512-200320100-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031740200
245 https://doi.org/10.2165/00002512-200320100-00005
246 rdf:type schema:CreativeWork
247 https://app.dimensions.ai/details/publication/pub.1079893102 schema:CreativeWork
248 https://doi.org/10.1016/s0140-6736(10)61389-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1005976220
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1021/jm950749y schema:sameAs https://app.dimensions.ai/details/publication/pub.1055957296
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1046/j.1365-2125.1998.00719.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1027361200
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1056/nejmoa040720 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029249997
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1056/nejmoa041318 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028543233
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1056/nejmoa1014618 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018044872
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1093/annonc/mdl498 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051931730
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1093/annonc/mdq050 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037456851
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1097/00008571-199204000-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060289224
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1111/j.1365-2710.2007.00815.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1012333988
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1158/0008-5472.can-07-5997 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051493123
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1158/0008-5472.can-08-0249 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017269047
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1158/1078-0432.ccr-11-0815 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038628088
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1200/jco.2007.12.4487 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031178629
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1200/jco.2008.20.0642 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011914597
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1200/jco.2009.24.1281 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013861469
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1200/jco.2009.24.6819 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033684430
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1200/jco.2009.25.9259 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026303880
283 rdf:type schema:CreativeWork
284 https://doi.org/10.2174/0929867054367185 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069160512
285 rdf:type schema:CreativeWork
286 https://doi.org/10.3322/ca.2007.0010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052065817
287 rdf:type schema:CreativeWork
288 https://www.grid.ac/institutes/grid.248762.d schema:alternateName BC Cancer Agency
289 schema:name British Columbia Cancer Agency, 600 West 10th Avenue, V5Z4E6, Vancouver, BC, Canada
290 rdf:type schema:Organization
291 https://www.grid.ac/institutes/grid.34474.30 schema:alternateName RAND Corporation
292 schema:name Janssen Research and Development LLC, Los Angeles, CA, USA
293 rdf:type schema:Organization
294 https://www.grid.ac/institutes/grid.477989.c schema:alternateName South Texas Accelerated Research Therapeutics
295 schema:name South Texas Accelerated Research Therapeutics, START Center for Cancer Care, San Antonio, TX, USA
296 rdf:type schema:Organization
297 https://www.grid.ac/institutes/grid.478023.a schema:alternateName Tower Cancer Research Foundation
298 schema:name Tower Cancer Research Foundation, Beverly Hills, CA, USA
299 rdf:type schema:Organization
300 https://www.grid.ac/institutes/grid.490448.5 schema:alternateName Providence Saint Joseph Medical Center
301 schema:name Providence Saint Joseph Medical Center, Burbank, CA, USA
302 rdf:type schema:Organization
303 https://www.grid.ac/institutes/grid.497530.c schema:alternateName Janssen (United States)
304 schema:name Janssen Research and Development LLC, Raritan, NJ, USA
305 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...